OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

41 hedge funds and large institutions have $33.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OCM
1
Ovata Capital Management
Hong Kong
$2.53M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$2.49M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$2.29M
4
HP
4
HealthInvest Partners
Sweden
$386K
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$364K

Top Sellers

1
EI
1
EAM Investors
California
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$832K
3
Wells Fargo
3
Wells Fargo
California
$4.4M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$0
5
CSS
5
Cubist Systematic Strategies
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SPWG
51
Sage Private Wealth Group
Illinois
$0 5 – –
Citigroup
52
Citigroup
New York
$0 10 +10 New
1 2
3